Cyclo(RGDfC), avb3 Integrin Binding Cyclic RGD Peptide

CAS862772-11-0

Cyclo(RGDfC), avb3 Integrin Binding Cyclic RGD Peptide (CAS 862772-11-0, C24H34N8O7S) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of Cyclo(RGDfC), avb3 Integrin Binding Cyclic RGD Peptide
C24H34N8O7S · 578.65 g/mol
CAS No.
862772-11-0
Formula
C24H34N8O7S
Mol. weight
578.65 g/mol

Chemical Specifications

Identifiers

CAS number 862772-11-0
Product name Cyclo(RGDfC), avb3 Integrin Binding Cyclic RGD Peptide
Molecular formula C24H34N8O7S
Molecular weight 578.65 g/mol

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of Cyclo(RGDfC), avb3 Integrin Binding Cyclic RGD Peptide?

The CAS Registry Number of Cyclo(RGDfC), avb3 Integrin Binding Cyclic RGD Peptide is 862772-11-0.

What is the molecular formula and molecular weight of Cyclo(RGDfC), avb3 Integrin Binding Cyclic RGD Peptide?

The molecular formula of Cyclo(RGDfC), avb3 Integrin Binding Cyclic RGD Peptide is C24H34N8O7S, and its molecular weight is 578.65 g/mol.

How can I request a quotation for Cyclo(RGDfC), avb3 Integrin Binding Cyclic RGD Peptide?

Send an inquiry for Cyclo(RGDfC), avb3 Integrin Binding Cyclic RGD Peptide (CAS 862772-11-0) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for Cyclo(RGDfC), avb3 Integrin Binding Cyclic RGD Peptide

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.